ATARA BIOTHERAPEUTICS INC (ATRA) Stock Analyst Earnings Estimates
NASDAQ:ATRA - Nasdaq - US0465132068 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20.34M | 63.57M 212.54% | 8.573M -86.51% | 118.42M 1,281.31% | 92.466M -21.92% | 72.807M -21.26% | 181.33M 149.06% | 249.94M 37.84% | 190.74M -23.69% | 247.86M 29.95% | 298.86M 20.58% | 340.68M 13.99% | |
| EBITDA YoY % growth | -331.11M -10.11% | -268.9M 18.79% | -264.447M 1.66% | -67.32M 74.54% | -59.16M 12.12% | -139.74M -136.21% | N/A | -139.74M | -120.36M 13.87% | 12.24M 110.17% | 88.74M 625.00% | 134.64M 51.72% | |
| EBIT YoY % growth | -340.46M -10.16% | -274.55M 19.36% | -269.276M 1.92% | -98.796M 63.31% | -93.431M 5.43% | -113.469M -21.45% | 17.058M 115.03% | 67.088M 293.29% | -144.84M -315.90% | -5.1M 96.48% | 76.5M 1,600.00% | 123.42M 61.33% | |
| Operating Margin | -1,673.84% | -431.89% | -3,140.98% | -83.43% | -101.04% | -155.85% | 9.41% | 26.84% | -75.94% | -2.06% | 25.60% | 36.23% | |
| EPS YoY % growth | -90.75 13.78% | -68.00 25.07% | -65.50 3.68% | -2.27 96.53% | -9.34 -310.61% | -1.68 81.98% | -2.93 -73.94% | -1.37 53.31% | 3.21 335.07% | 2.99 -6.98% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.52 74.86% | -3.88 32.59% | -3.52 -13.52% | -0.63 78.53% | -2.65 24.64% |
| Revenue Q2Q % growth | 20.48M 381.66% | 9.928M -63.71% | 9.928M -65.34% | 30.702M -23.61% | 8.568M -58.16% |
| EBITDA Q2Q % growth | N/A | -22.44M 10.62% | -21.42M -41.35% | -24.48M -37.48% | N/A |
| EBIT Q2Q % growth | -26.46M 50.33% | -28.05M -5.87% | -24.225M -35.52% | -23.205M -6.66% | -18.36M 30.61% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -2.93 82.24% | -1.97 | -0.96 | -48.64% |
| Q2 2024 Q2Q % growth | -3.10 81.76% | -1.59 | -1.51 | -94.51% |
| Q1 2024 Q2Q % growth | -5.75 68.06% | -6.54 | 0.79 | 12.03% |
| Q4 2023 Q2Q % growth | -14.00 22.22% | -12.29 | -1.71 | -13.90% |
| Q3 2023 Q2Q % growth | -16.50 19.51% | -16.88 | 0.38 | 2.26% |
| Q2 2023 Q2Q % growth | -17.00 -119.35% | -17.15 | 0.15 | 0.85% |
| Q1 2023 Q2Q % growth | -18.00 17.24% | -9.99 | -8.01 | -80.21% |
| Q4 2022 Q2Q % growth | -18.00 25.00% | -12.95 | -5.05 | -39.04% |
| Q3 2022 Q2Q % growth | -20.50 8.89% | -20.02 | -0.48 | -2.41% |
| Q2 2022 Q2Q % growth | -7.75 65.93% | -23.61 | 15.86 | 67.18% |
| Q1 2022 Q2Q % growth | -21.75 -1.16% | -24.99 | 3.24 | 12.98% |
| Q4 2021 Q2Q % growth | -24.00 -1.05% | -17.48 | -6.52 | -37.30% |
| Q3 2021 Q2Q % growth | -22.50 2.17% | -23.90 | 1.40 | 5.85% |
| Q2 2021 Q2Q % growth | -22.75 20.18% | -22.74 | -0.01 | -0.05% |
| Q1 2021 Q2Q % growth | -21.50 28.33% | -23.47 | 1.97 | 8.39% |
| Q4 2020 Q2Q % growth | -23.75 30.15% | -18.98 | -4.77 | -25.13% |
| Q3 2020 Q2Q % growth | -23.00 29.77% | -27.71 | 4.71 | 17.01% |
| Q2 2020 Q2Q % growth | -28.50 28.75% | -30.16 | 1.66 | 5.50% |
| Q1 2020 Q2Q % growth | -30.00 16.67% | -36.07 | 6.07 | 16.82% |
| Q4 2019 Q2Q % growth | -34.00 | -34.17 | 0.17 | 0.50% |
| Q3 2019 Q2Q % growth | -32.75 | -36.76 | 4.01 | 10.90% |
| Q2 2019 Q2Q % growth | -40.00 | -38.15 | -1.85 | -4.85% |
| Q1 2019 Q2Q % growth | -36.00 | -38.61 | 2.61 | 6.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 40.19M 1,779.79% | 35.871M | 4.319M | 12.04% |
| Q2 2024 Q2Q % growth | 28.64M 2,892.69% | 40.79M | -12.15M | -29.79% |
| Q1 2024 Q2Q % growth | 27.357M 2,131.40% | 25.184M | 2.173M | 8.63% |
| Q4 2023 Q2Q % growth | 4.252M 1,832.73% | 11.783M | -7.531M | -63.91% |
| Q3 2023 Q2Q % growth | 2.138M -52.06% | 4.853M | -2.715M | -55.94% |
| Q2 2023 Q2Q % growth | 957K -98.14% | 3.843M | -2.886M | -75.10% |
| Q1 2023 Q2Q % growth | 1.226M -83.23% | 31.291M | -30.065M | -96.08% |
| Q4 2022 Q2Q % growth | 220K -97.09% | 40.466M | -40.246M | -99.46% |
| Q3 2022 Q2Q % growth | 4.46M -16.95% | 5.381M | -921K | -17.12% |
| Q2 2022 Q2Q % growth | 51.58M 1,232.82% | 6.974M | 44.606M | 639.60% |
| Q1 2022 Q2Q % growth | 7.31M 105.92% | 5.011M | 2.299M | 45.88% |
| Q4 2021 Q2Q % growth | 7.55M | 35.846M | -28.296M | -78.94% |
| Q3 2021 Q2Q % growth | 5.37M | 4M | 1.37M | 34.25% |
| Q2 2021 Q2Q % growth | 3.87M | 3.918M | -48K | -1.23% |
| Q1 2021 Q2Q % growth | 3.55M | 1.629M | 1.921M | 117.93% |
| Q4 2020 Q2Q % growth | 13.6M | -13.6M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -38.93% | -2231.08% | 73.28% | 70.4% |
| Revenue | -26.53% | -20.8% | -4.07% | 7.01% |